TW200540160A - Process for the production of 5-difluoromethoxy -4-thiomethylpyrazoles - Google Patents

Process for the production of 5-difluoromethoxy -4-thiomethylpyrazoles Download PDF

Info

Publication number
TW200540160A
TW200540160A TW94113484A TW94113484A TW200540160A TW 200540160 A TW200540160 A TW 200540160A TW 94113484 A TW94113484 A TW 94113484A TW 94113484 A TW94113484 A TW 94113484A TW 200540160 A TW200540160 A TW 200540160A
Authority
TW
Taiwan
Prior art keywords
alkyl
group
branched
general formula
methyl
Prior art date
Application number
TW94113484A
Other languages
Chinese (zh)
Inventor
Yukio Uchida
Original Assignee
Ihara Chemical Ind Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ihara Chemical Ind Co filed Critical Ihara Chemical Ind Co
Publication of TW200540160A publication Critical patent/TW200540160A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5

Description

200540160 (1) 九、發明說明 【發明所屬之技術領域】 本發明係有關5-二氟化甲氧基-4-硫甲基吡唑化合物 的製造方法。 【先前技術】 由本發明所得之5-二氟化甲氧基-4_硫甲基吡唑化合 物係有用於作爲醫藥及農藥製造的中間物。 得到5-二氟化甲氧基吡唑化合物的方法,已知將5-羥 基吡唑化合物與氯二氟甲烷於N,N-二甲基甲醯胺溶劑中, 於碳酸氫鉀的存下反應的方法(參閱非專利文獻1),二噁 烷與水的混合溶劑中,於氫氧化鈉的存在下反應的方法( 參閱專利文獻1)。 但是,有關對於5-二氟化甲氧基-4·硫甲基吡唑化合 物,使用氯二氟甲烷得到5-二氟化甲氧基-4-硫甲基吡唑 化合物的方法爲未知。 一方面,5-二氟化甲氧基-4-硫甲基吡唑化合物,存在 酮烯醇互變異性物,酮型化合物可理解爲持有電子收回基 烴之硫化物的麥克加成生成物,一般,該種麥克加成爲可 逆,生成物與強鹼同時加熱時,知其硫化合物脫離(參閱 非專利文獻2)。又,強鹼的條件下,使用氯二氟甲烷,由 5-羥基-4-硫甲基吡唑化合物得到5·二氟化甲氧基-4-硫甲 基吡唑化合物時,例如,於醇溶劑中反應時,反應競相進 行,引起原料的分解爲既知者(參閱非專利文獻2)。 200540160 (2) 專利文獻1 :國際公開公報W09 5 M 9967 非專利文獻1 :藥品化學定期刊物,第43卷-1 6號’ 2975 - 29 8 1 Μ (2000 $ ) 非專利文獻2 :有機合成硫化合物的任務(日本三共 出版股份有限公司)5.5.2章,171-174頁,(1981年) 【發明內容】 【發明所欲解決之課題】 本發明爲提供5-羥基-4-硫甲基吡唑化合物使用氯二 氟甲烷有效率製造5-二氟化甲氧基-4-硫甲基吡唑化合物 的新穎的方法。 【課題解決手段】 有鑑於上述狀況,本發明者深入硏究5 -二氟化甲氧 基-4-硫甲基吡唑化合物的製造方法的結果,意外的,發現 φ 將5-羥基-4-硫甲基吡唑化合物與氯二氟甲烷,鹼使用氫 氧化鈉,於碳數1至3 (以下有關碳數,例如碳數1至3 時,以「C1〜C3」略記)的二(C1〜C3烷基)酮或 (C1〜C3烷基)腈的存在下反應,發現可解決上述課題。 以此硏究爲基礎完成本發明。 【發明之效果】 由本發明的方法’提供5-二氟化甲氧基-4_硫甲基吡 唑化合物的新穎工業的製造方法,使用5-羥基-4-硫甲基 -6 - 200540160 (3) -4 -硫 料或 價値 口比D坐化合物與_化一氟甲院爲原料,5 -二氟化甲氧 甲基吡唑化合物可簡便操作製造。又,本發明方法 生成物的分解少’反應時間亦大幅縮短,工業的利 高。 【用以實施發明之最佳型態】 以下,詳細說明本發明。 決上 本發明,係由下述[1]至[4]所記載的發明 述課題者。 [1] 一般式(1)200540160 (1) IX. Description of the invention [Technical field to which the invention belongs] The present invention relates to a method for producing a 5-difluoromethoxy-4-thiomethylpyrazole compound. [Prior art] The 5-difluoromethoxy-4_thiomethylpyrazole compound obtained by the present invention is used as an intermediate for the manufacture of medicine and pesticides. A method for obtaining a 5-difluorinated methoxypyrazole compound. It is known that a 5-hydroxypyrazole compound and chlorodifluoromethane are dissolved in a N, N-dimethylformamide solvent in the presence of potassium bicarbonate. A method of reaction (see Non-Patent Document 1), a method of reacting in a mixed solvent of dioxane and water in the presence of sodium hydroxide (see Patent Document 1). However, a method for obtaining a 5-difluoromethoxy-4-thiomethylpyrazole compound using chlorodifluoromethane for a 5-difluoromethoxy-4 · thiomethylpyrazole compound is unknown. On the one hand, 5-difluorinated methoxy-4-thiomethylpyrazole compounds have ketoenol tautomers, and keto compounds can be understood as the addition of sulfide compounds that possess electron-recovering hydrocarbons. In general, this type of mecca becomes reversible, and when the product is heated simultaneously with a strong base, the sulfur compound is known to be detached (see Non-Patent Document 2). When a chlorodifluoromethane is used under strong base conditions to obtain a 5 · difluoromethoxy-4-thiomethylpyrazole compound from a 5-hydroxy-4-thiomethylpyrazole compound, for example, at When reacting in an alcohol solvent, the reactions proceed in a race to cause decomposition of the raw materials to known ones (see Non-Patent Document 2). 200540160 (2) Patent Document 1: International Publication W09 5 M 9967 Non-Patent Document 1: Fixed Journal of Pharmaceutical Chemistry, Volume 43-1 No. 6 '2975-29 8 1 Μ (2000 $) Non-Patent Document 2: Organic Synthesis Tasks of Sulfur Compounds (Japan Sankyo Publishing Co., Ltd.) Chapter 5.5.2, pages 171-174, (1981) [Summary of the Invention] [Questions to be Solved by the Invention] The present invention provides 5-hydroxy-4-thiomethyl A novel method for efficiently producing 5-difluoromethoxy-4-thiomethylpyrazole compounds using chlorodifluoromethane. [Means for solving the problem] In view of the above-mentioned situation, the present inventors have intensively studied the results of a method for producing a 5-difluoromethoxy-4-thiomethylpyrazole compound, and unexpectedly found that φ will be 5-hydroxy-4 -Thiomethylpyrazole compound and chlorodifluoromethane, sodium hydroxide as base, carbon number 1 to 3 (for carbon numbers below, for example, carbon number 1 to 3, abbreviated as "C1 ~ C3") ( The reaction was performed in the presence of C1 to C3 alkyl) ketone or (C1 to C3 alkyl) nitrile, and it was found that the above-mentioned problems can be solved. The present invention has been completed based on this research. [Effect of the Invention] A novel industrial manufacturing method for providing a 5-difluoromethoxy-4-4-thiomethylpyrazole compound by the method of the present invention, using 5-hydroxy-4-thiomethyl-6-200540160 ( 3) -4 -Sulfur materials or valence ratios of D compounds and fluorinated methyl fluoride as raw materials, 5-difluoromethoxymethylpyrazole compounds can be easily manufactured. Moreover, the reaction time of the product of the method of the present invention is reduced, and the reaction time is greatly shortened, which is industrially advantageous. [Best Mode for Carrying Out the Invention] Hereinafter, the present invention will be described in detail. The present invention was made by the subject of the invention described in the following [1] to [4]. [1] General formula (1)

具有 具有 〇或 •(式中,尺!爲烷基、可具有取代基之芳香族烴基或5 取代基之雜環基,R2爲電子收回基、R3爲烷基、5 取代基之芳香族烴基或可具有取代基之雜環基,η爲 2) 所示之5-羥基-4-硫甲基吡唑化合物,與一般式(2) CHF2 X (2) (式中,X爲鹵原子) R2It has an aromatic hydrocarbon group having 〇 or • (in the formula! Is an alkyl group, an aromatic hydrocarbon group which may have a substituent or a 5-substituent heterocyclic group, R2 is an electron recovering group, R3 is an alkyl group, and an aromatic hydrocarbon group having 5 substituents. Or a heterocyclic group which may have a substituent, wherein η is a 5-hydroxy-4-thiomethylpyrazole compound represented by 2), and a general formula (2) CHF2 X (2) (wherein X is a halogen atom) R2

II

200540160 (4) 所示之鹵化二氟甲烷,於二(C1〜C3烷基)酮或 C3烷基)腈、及氫氧化鈉的存在下反應爲特徵之 (3) •S(〇)n—R3 、OCHF2 ⑶ (式中R】、R2、R3及n意義與上述相同)。 所示之 5-二氟化甲氧基-4-硫甲基吡唑化合物的製 〇 [2] —般式(2)中之X爲氯之上述[1]所記 造方法。 [3] n爲0之上述[1]或[2]所記載的製造方 [4] n爲2之上述[1]或[2]所記載的製造方 [5] 反應係於具有水捕集作用之添加劑存在下 [1]至[4]中任一項所記載的製造方法。 [6] 具有水捕集水作用之添加劑爲選自無水硫 氯化#§、及碳酸鈉所成群之至少1種之上述[5] 的製造方法。 以下詳細說明本發明。 本發明爲一般式(1)所示之5-羥基-4-硫甲基 合物’與一般式(2)所示之鹵化二氟甲烷,於二 C3院基)酮或(C1〜C3烷基)腈、及氫氧化鈉的 反應爲特徵之一般式(3)所示之5-二氟化甲氧基· -8 - (C1〜 一般式 造方法 載的製 法。 法。 進行之 酸鈉、 所記載 吡唑化 (C1〜 存在下 4-硫甲 200540160 (5) 基吡唑化合物的製造方法。 首先,說明本發明方法的原料之一般式(1)所示之 原料化合物。 一般式 (1)中的R!,可例示如包含例如甲基、乙基 、η-丙基、異丙基、η-丁基、sec-丁基、t-丁基、η-戊基、 η-己基等的直鏈或分枝C1〜C6烷基;例如苯基、萘基等 的單環或縮合環的C6〜C10芳香烴基(該芳香族烴基爲 例如具有溴、氯、氟、碘等的鹵原子:例如甲基、乙基、 η-丙基、異丙基、η-丁基、sec-丁基、t-丁基、n-戊基、n-己基等的直鏈或分枝Cl〜C6烷基;例如甲氧基、乙氧基 、η-丙氧基、異丙氧基等的直鏈或分枝C1〜C6烷氧基; 例如甲氧甲基、1-甲氧乙基、1_乙氧乙基等的直鏈或分枝 (C1〜C6烷氧基)-(C1〜C6烷基)基;例如氟甲基、二 氟甲基、三氟甲基等的直鏈或分枝C1〜C6鹵化烷基;羧 基;例如甲氧羰基、乙氧羰基等的直鏈或分枝 (C1〜C6 烷氧基)羰基;硝基;例如、甲氧羰甲基、1-甲氧羰乙基 、1·乙氧羰乙基等的直鏈或分枝(C1〜C6烷氧基)羰 基-(C1〜C6烷基)基;氰基等的取代基亦可);例如呋 喃基、苯并呋喃基、吡啶基、噻吩基、苯并噻吩基、噁唑 啉基、苯并噁唑啉基、噻唑基、苯并噻唑基、異噁唑啉基 、噻二唑基、吡嗪基、嘧啶基、吲哚基、D奎啉基、吡唑啉 基、咪唑啉基、苯并咪唑啉基、三唑基、三畊基、等爲代 表的具有1至4個由氮原子、氧原子、硫原子所選的至少 一種異項原子,構成環的原子數爲5至14,理想爲5至 -9- 200540160 (6) 10的單環或縮合環的芳香族雜環基(該芳香族雜環基, 例如具有溴、氯、氟、姚等的鹵原子、例如甲基、乙基、 η·丙基、異丙基、η -丁基、sec -丁基、t -丁基、η -戊基、n_ 己基等的直鏈或分枝Cl〜C6烷基;例如甲氧基、乙氧基 、η-丙氧基、異丙氧基等的直鏈或分枝C1〜C6烷氧基; 例如甲氧甲基、1-甲氧乙基、1-乙氧乙基等的直鏈或分枝 (C1〜C6烷氧基)-(C1〜C6烷基)基;例如氟甲基、二 φ 氟甲基、三氟甲基等的直鏈或分枝C1〜C6鹵化烷基;羧 基;例如甲氧羰基、乙氧羰基等的直鏈或分枝 (C1〜C6 烷氧基)羰基;硝基;例如、甲氧羰甲基、1-甲氧羰乙基 、1-乙氧羰乙基等的直鏈或分枝(C1〜C6烷氧基)羰 基-(C1〜C6烷基);氰基等的取代基亦可);或例如氫呋 喃基、吡喃基、四氫噻吩基(thiolanyl )、噻基(thianyl )、吡咯烷基、吲哚滿基、四氫化吡啶基、咪唑啉基、哌 嗪基等爲代表的具有1至4個由氮原子、氧原子、硫原子 φ 所選的至少一種異項原子,構成環的原子數爲5至14,理 想爲5至10的單環或縮合環的不具有芳香族性雜環基( 該不具有芳香族雜環基,例如具有1個以上溴、氯、氟、 碘等的鹵原子;例如甲基、乙基、n -丙基、異丙基、n-丁 基、sec-丁基、t-丁基、n-戊基、n-己基等的直鏈或分枝 C1〜C6烷基;例如甲氧基、乙氧基、η_丙氧基、異丙氧 基等的直鏈或分枝C1〜C6烷氧基;例如羥甲基、羥乙基 等的直鏈或分枝C1〜C6羥烷基;例如甲氧甲基、甲氧乙 基、乙氧乙基等的直或分枝(C1〜C6烷氧基)-(C1〜C6 -10- 200540160 (7) 烷基)基;例如氟甲基、二氟甲基、三氟甲基等的直鏈或 分枝C1〜C6鹵化烷基;羧基;或其鈉鹽、鉀鹽、鋰鹽等 的鹼金屬鹽或鈣鹽、鋇鹽、鎂鹽等的鹼土金屬鹽所代表的 羧基金屬鹽;例如甲氧羰基、乙氧羰基等的直鏈或分枝 (C1〜C6烷氧基)羰基;例如溴、氯、氟、碘等的鹵原子 ;硝基;胺基;例如甲基胺基、二甲基胺基、乙基胺基、 二乙基胺基等的直鏈或分枝的單或二(C1〜C6烷基)胺 φ 基、例如乙醯胺基、丙醯胺基丁醯胺基等的直鏈或分枝 (C1〜C6烷基)羰基胺基;氰基;甲醯基;例如甲基羰基 、乙基羰基等的直鏈或分枝(C1〜C6烷基)羰基;例如 苯醯基、萘醯基等環的構成原子數爲6至14,理想爲6〜 10的芳基羰基:例如吡啶羰基、噻吩羰基、呋喃羰基等的 具有1至4個由氮原子、氧原子、硫原子所選的至少一種 異項原子,構成環的原子數爲5至14,理想爲5至10的 單環或縮合環的雜環芳基羰基的取代基亦可),具有或不 φ 具有芳香族性雜環基等。 一般式(1)中的R2所示之電子收回基,係意味以誘 發效果由對手吸引電子之原子團,具體的,例如具有1個 以上二氟甲基、三氟甲基等的直鏈或分枝的C1〜C6鹵化 烷基;羧基;例如例如甲氧羰基、乙氧羰基等的直鏈或分 枝 (C1〜C6烷氧基)羰基;例如溴、氯、氟、碘等的鹵 原子;硝基;甲醯基;例如甲基羰基、乙基羰基等的直鏈 或分枝(C1〜C6烷基)羰基;胺基羰基;例如甲基胺基 羰基等的直鏈或分枝(C1〜C6烷基)胺基羰基;例如二 -11 - 200540160 (8) 甲基胺基羰基等的直鏈或分枝二(Cl〜C6烷基)胺基羰基 ;氰基;例如氯苯基、乙醯苯基、硝基苯基、乙醯萘基等 爲代表的取代基,以誘發效果由對手吸引電子之原子團( 例如於上所述之以誘發效果由對手吸引電子之原子團的示 例之直鏈或分枝C1〜C6鹵烷基;羧基;直鏈或分枝(C1 〜C6烷氧基)羰基;鹵原子;硝基;甲醯基;直鏈或分枝 (C1〜C6烷基)羰基;胺基羰基;直鏈或分枝 (C1〜C6 烷基)羰基;直鏈或分枝二(C1〜C6烷基)胺基羰基; 氰基等原子團)之單環或縮合環的C6〜C10芳香族烴基 ;氰基吡啶基、氯吩基、硝基呋喃基、甲醯基吡啶基等爲 代表的取代基,具有1個以上以誘發效果由對手吸引電子 之原子團(例如於上所述之以誘發效果由對手吸引電子之 原子團的示例之直鏈或分枝C1〜C6鹵烷基;羧基;直鏈 或分枝 (C1〜C6烷氧基)羰基;鹵原子;硝基;甲醯基 :直鏈或分枝 (C1〜C6烷基)羰基;胺基羰基;直鏈或 分枝 (C1〜C6烷基)胺基羰基;直鏈或分枝二(C1〜C6 烷基)胺基羰基;氰基等的原子團),具有1至4個由氮 原子、氧原子、硫原子所選的至少一種異項原子,構成環 的原子數爲5至14,理想爲5至10的單環或縮合環的雜 環芳基羰基等。 又,一般式(1)中的R3所示之取代基,包含例如甲 基、乙基、η·丙基、異丙基、η-丁基、sec-丁基、t_丁基、 η·戊基、η-己基等的直鏈或分枝C1〜C6烷基;苯基、萘 基等的單環或縮合環的C6〜C10芳香族烴基(該芳香族 -12- 200540160 (9) 烴基例如具有溴、氯、氟、碘等的鹵原子;例如甲基、乙 基、η -丙基、異丙基、η -丁基、sec -丁基、t -丁基、η -戊基 、η-己基等的直鏈或分枝C1〜C6烷基;羥基;例如甲氧 基、乙氧基、η-丙氧基、異丙氧基等的直鏈或分枝C1〜 C6烷氧基;例如甲氧甲基、1-甲氧乙基、1-乙氧乙基等的 直鏈或分枝 (C1〜C6烷氧基)-(Cl〜C6烷基)基;例如 氟甲基、二氟甲基、三氟甲基等的直鏈或分枝C1〜C6鹵 φ 化烷基;羧基;例如甲氧羰基、乙氧羰基等的直鏈或分枝 (C1〜C6烷氧基)羰基;例如、甲氧羰甲基、1-甲氧羰乙 基、1-乙氧羰乙基等的直鏈或分枝 (C1〜C6烷氧基) 羰基-(C1〜C6烷基)基;氰基等的取代基亦可);例如 呋喃基、苯并呋喃基、吡啶基、噻吩基、苯并噻吩基、噁 唑啉基、苯并噁唑啉基、噻唑基、苯并噻唑基、異噁唑啉 基、噻二唑基、吡嗪基、嘧啶基、吲哚基、喹啉基、吡唑 啉基、咪唑啉基、苯并咪唑啉基、三唑基、三哄基、等爲 φ 代表的具有1至4個由氮原子、氧原子、硫原子所選的至 少一種異項原子,構成環的原子數爲5至14,理想爲5至 10的單環或縮合環的芳香族雜環基(該芳香族雜環基, 例如溴、氯、氟、碘等的鹵原子、例如甲基、乙基、η-丙 基、異丙基、丁基、sec-丁基、t-丁基、η-戊基、η-己基 等的直鏈或分枝C1〜C6烷基;羥基;例如甲氧基、乙氧 基、η-丙氧基、異丙氧基等的直鏈或分枝C1〜C6烷氧基 :例如甲氧甲基、1-甲氧乙基、1-乙氧乙基等的直鏈或分 枝 (C1〜C6烷氧基)-(C1〜C6烷基)基;例如氟甲基、 -13- 200540160 (10) 二氟甲基、三氟甲基等的直鏈或分枝Cl〜C6鹵化烷基; 羧基;例如甲氧羰基、乙氧羰基等的直鏈或分枝 (C1〜 C6烷氧基)羰基;硝基;例如、甲氧羰甲基、1·甲氧羰 乙基、1-乙氧羰乙基等的直鏈或分枝(C1〜C6烷氧基) 羰基-(C1〜C6烷基);氰基等的取代基亦可);或例如氫 呋喃基、吡喃基、四氫噻吩基(Thioranyl )、噻基( thianyl )、吡咯烷基、吲哚滿基、四氫化吡啶基、咪唑啉 基、哌嗪基等爲代表的具有1至4個由氮原子、氧原子、 硫原子所選的至少一種異項原子,構成環的原子數爲5至 14,理想爲5至10的單環或縮合環的不具有芳香族性雜 環基(該不具有芳香族雜環基,例如具有1個以上溴、氯 、氟、碘等的鹵原子、例如甲基、乙基、η-丙基、異丙基 、η-丁基、sec-丁基、t-丁基、η-戊基、η-己基等的直鏈或 分枝C1〜C6烷基;羥基;例如甲氧基、乙氧基、η-丙氧 基、異丙氧基等的直鏈或分枝C1〜C6垸氧基;例如甲氧 甲基、甲氧乙基、乙氧乙基等的直鏈或分枝(C1〜C6烷 氧基)—(C1〜C6烷基)基;例如氟甲基、二氟甲基、三 氟甲基等的直鏈或分枝C1〜C6鹵化烷基;羧基;或其鈉 鹽、鉀鹽、鋰鹽等的鹼金屬鹽或鈣鹽、鋇鹽、鎂鹽等的鹼 土金屬鹽所代表的羧基金屬鹽;例如甲氧羰基、乙氧羰基 等的直鏈或分枝(C1〜C6烷氧基)羰基;例如溴、氯、 氟、碘等的鹵原子;硝基;胺基;例如甲基胺基、二甲基 胺基、乙基胺基、二乙基胺基等的直鏈或分枝的單或二 (C 1〜C6烷基)胺基、例如乙醯胺基、丙醯胺基丁醯胺基 -14- 200540160 (11) 等的直鏈或分枝(C1〜C6烷基)羰基胺基;氰基;甲醯 基;例如甲基羰基、乙基羰基等的直鏈或分枝(C1〜C6烷 基)羰基;例如苯醯基、萘醯基等環的構成原子數爲6至 14,理想爲6〜10的芳基羰基等的具有1至4個由氮原子 、氧原子、硫原子所選的至少一種異項原子,構成環的原 子數爲5至14,理想爲5至10的單環或縮合環的雜環芳 基羰基的取代基亦可),具有或不具有芳香族性雜環基等 〇 一般式(1)中的η爲0時一般式(1)所示的之化合 物爲硫化物,η爲2時一般式(2)所示之化合物爲碼類 。一般式(1)所示的5-羥基-4-硫甲基吡唑化合物爲公知 化合物,或,例如後述參考例1〜4所述由5-羥基吡唑類 與甲醛及硫化合物的反應,可容易合成。 接著說明一般式(2)所示之鹵化二氟甲烷。 一般式(2)中之X爲氟、氯、溴、碘等的原子。 因此,於本反應可使用之一般式(2)之鹵化二氟甲 烷,具體的可例示如三氟甲烷、氯二氟甲烷、溴二氟甲烷 、二氟碘甲烷。理想可舉例如氯二氟甲烷、溴二氟甲烷, 特別理想爲氯二氟甲烷。 此等一般式(2)所示鹵化二氟甲烷的使用莫耳比, 相對於一般式(1)所示的5-羥基-4-硫甲基吡唑化合物以 任何莫耳比均可進行反應。其中亦以相對於一般式 (1) 所示的5-羥基-4-硫甲基吡唑化合物1莫耳比,一般式 (2)所示鹵化二氟甲烷通常爲0.1〜10.0莫耳比,理想爲 -15- 200540160 (12) 1.0〜5.0莫耳比,更理想爲1.3〜2.2莫耳比的範圍。 本反應可使用氫氧化鈉進行。於本反應使用之氫氧化 鈉,爲固體狀的氫氧化鈉即可,以市售的96%氫氧化鈉, 或可入手的工業品顆粒狀的99%氫氧化鈉爲理想,特別以 9 9 %氫氧化鈉爲更理想。 氫氧化鈉的使用量,以反應可充分進行的者多少均可 。其中,相對於1莫耳一般式(1)所示的5-羥基-4·硫甲 基吡唑化合物爲1.0〜20莫耳,理想爲1.5〜10莫耳,更 理想爲2.0〜3.0莫耳的範圍。 於本反應,添加劑推測爲捕捉反應系內隨反應進行副 產生之水的工作,將無水硫酸鈉、氯化鈣、及 /或碳酸 鈉於反應系內共存,特別是放大產量時產率狀況可安定提 高。又,由添加該添加劑,抑制鹵化二氟甲烷的水解,其 結果,關聯鹵化二氟甲烷使用量的削減。添加劑的使用量 無特別的限制,相對於1莫耳一般式(1)所示的5-羥基-4-硫甲基吡唑化合物爲0.01〜20莫耳,理想爲0.1〜1 〇 莫耳,更理想爲0.2〜5.0莫耳的範圍可發揮充分的效果 。由本發明者的觀察,該添加劑推測爲捕捉反應系內隨反 應進行副產生之水的工作,可捕捉反應系內隨反應進行副 產生之水的工作可使用上述例示以外的物質,本發明亦包 含此等物質。 本反應例如可在丙酮、甲乙基酮等的二(C1〜C3烷 基)酮;或例如乙醯腈、丙醯腈等的(C1〜C3烷基)腈 的存在下實施。通常,兼爲反應的溶劑,反應系可充分攪 -16- 200540160 (13) 拌使用過剩量,具體的相對於一般式(1)所示之原料化 合物1莫耳,通常爲0.05〜10 L,理想爲爲0.3〜5 L, 更理想爲0.5〜2 L的範圍者即可。 單獨使用二(C1〜C3烷基)酮、(C1〜C3烷基)腈 ,或對反應無障礙的溶劑,例如可混合於甲苯、二甲苯、 氯苯等的芳香族烴;二氯甲烷、氯仿等的鹵化脂肪族烴; 二乙醚、二異丙醚等的醚系溶劑;戊烷、己烷等的脂肪 φ 族烴等使用。但是,二(C1〜C3烷基)酮、(C1〜C3烷 基)腈的混合比率極端的減低,反應速度隨著下降不理想 ,相對於芳香族烴等的混合之溶劑之混合比率(容量比) 爲1以上(即芳香族烴等的混合之溶劑爲等量以上)者爲 理想,將二(C1〜C3烷基)酮、(C1〜C3烷基)腈,與 不妨礙反應的溶劑混合使用時,其使用量爲上述範圍(相 對於一般式 (1)所示之原料化合物1莫耳二 (C1〜C3 烷基)酮、(C1〜C3烷基)腈,通常爲〇·〇1〜10 L,理 φ 想爲0.3〜5L,更理想爲0.5〜2L的範圍)。 全溶劑量,以反應系可充分攪拌的量爲佳,相對於一 般式(1)所示之原料化合物1莫耳通常爲〇·〇1〜L, 理想爲0.5〜2 L的範圍爲佳。 本反應的反應溫度,必要於-l〇°C〜35°C進行,兼 顧反應速度以0 t 〜10°C爲理想。 本反應的反應時間無特別的限制,反應速度,依一般 式(2)所示鹵化二氟甲烷的導入速度而變化。通常爲1 小時〜30小時完成反應。 -17- 200540160 (14) 於反應添加各成分的順序及反應方法無特別限制。合 適的例可舉於有機層中加鹼,於其中添加一般式(1)所 示的原料合物成爲懸浮狀,其次,由導入一般式(2)所 示鹵化二氟甲烷進行反應,得到一般式(3)所示的生成 物的方法。 依本反應,將一般式(1)所示的5-羥基-4-硫甲基吡 口坐化合物,與一般式(2)所示鹵化二氟甲烷於氫氧化鈉 φ 的存在下,使用二(C1〜C3烷基)酮、(C1〜C3烷基) 腈’生成一般式(3)所示之5-二氟化甲氧基-4-硫甲基吡 唑化合物,有用於作爲醫藥、農藥的中間物之化合物。 【實施方式】 以下舉參考例及實施例具的說明本發明的製造方法, 本發明不限於實施例。 φ (參考例1) 3-[(5-羥基-1-甲基·3-三氟甲基吡唑-4-醯)-甲基 硫卜4,5-二氫-5,5-二甲基異噁唑的合成 5-羥基-1·甲基-3-三氟甲烷吡唑1.7 g (10 mmol)與氫 氧化鈉K6 g (40 mmol)溶劑於10 ml水。該溶液於室溫 攪拌後,滴入35%甲醛水溶液 (35%福馬林溶液)1.7 g (20 mmol),於同溫攪拌1小時。於此,滴入[5,5-二甲基 (4,5-二氫異 D惡哗-3-醯)]噻殘脒(thiocarboxamidine)鹽 酸鹽2.1 g (10 mmol)的水溶液1〇 ml’攪拌2小時。反 應後,滴入35°/。鹽酸5.0 g (50 mmol)。將析出之結晶吸濾 -18- 200540160 (15) 後,以5 ml水洗淨2次。以溫風乾燥機乾燥,得到主題 化合物2· 5 g (產率80.1 %)的淡黃色結晶。所得之結晶 ,以η-己烷/ 2-丙醇混合溶劑再結晶,得到白色結晶。 ]H-NMR 値 (3 00 MHz,MeOH-d4) : 〇 = 4.88 (br,lH),4.08 (s,2H),3.64 (s,3H),2.91 (s,2H),】·39 (s,6H) ppm o200540160 (4) The halogenated difluoromethane shown in (4) is characterized by the reaction in the presence of bis (C1 ~ C3 alkyl) ketone or C3 alkyl) nitrile, and sodium hydroxide. (3) • S (〇) n— R3, OCHF2 (wherein R], R2, R3 and n have the same meaning as above). Preparation of the 5-difluoromethoxy-4-thiomethylpyrazole compound shown. [2]-The method described in the above [1] where X in general formula (2) is chlorine. [3] The manufacturer described in [1] or [2] where n is 0 [4] The manufacturer described in [1] or [2] where n is 2 [5] The reaction is based on water capture The production method described in any one of [1] to [4] in the presence of a functional additive. [6] The additive having a water-trapping effect is the production method of the above-mentioned [5], which is at least one selected from the group consisting of anhydrous sulfur chloride # § and sodium carbonate. The present invention is described in detail below. The present invention is a 5-hydroxy-4-thiomethyl compound represented by the general formula (1) and a halogenated difluoromethane represented by the general formula (2), in a di-C3 alkyl group, or a ketone or (C1 ~ C3 alkane). The reaction of acrylonitrile and sodium hydroxide is characterized by the reaction of 5-difluorinated methoxy · -8-(C1 ~ general formula), which is characterized by the general formula (3). The method of producing pyrazolyl (C1 ~ 4-thiomethyl 200540160 (5) in the presence of (5) based pyrazole compounds. First, the raw material compound represented by the general formula (1) of the raw material of the method of the present invention will be described. General formula ( Examples of R! In 1) include, for example, methyl, ethyl, η-propyl, isopropyl, η-butyl, sec-butyl, t-butyl, η-pentyl, and η-hexyl. And other straight or branched C1 ~ C6 alkyl groups; for example, monocyclic or condensed C6 ~ C10 aromatic hydrocarbon groups such as phenyl, naphthyl, etc. (the aromatic hydrocarbon groups are halogens having bromine, chlorine, fluorine, iodine, etc. Atom: For example, methyl, ethyl, η-propyl, isopropyl, η-butyl, sec-butyl, t-butyl, n-pentyl, n-hexyl, etc. C6 alkyl; for example, methoxy, ethoxy Straight-chain or branched C1 ~ C6 alkoxy groups such as methyl, η-propoxy, isopropoxy, etc .; for example, methoxymethyl, 1-methoxyethyl, 1-ethoxyethyl, etc. Branched (C1 ~ C6 alkoxy)-(C1 ~ C6 alkyl) groups; for example, linear or branched C1 ~ C6 halogenated alkyl groups such as fluoromethyl, difluoromethyl, trifluoromethyl, etc .; carboxyl groups; For example, linear or branched (C1 ~ C6 alkoxy) carbonyl groups such as methoxycarbonyl and ethoxycarbonyl; nitro; for example, methoxycarbonylmethyl, 1-methoxycarbonylethyl, 1 · ethoxycarbonylethyl Straight-chain or branched (C1 ~ C6 alkoxy) carbonyl- (C1 ~ C6 alkyl) groups; substituents such as cyano may also be used); for example, furyl, benzofuryl, pyridyl, thiophene Base, benzothienyl, oxazoline, benzoxazoline, thiazolyl, benzothiazolyl, isoxazoline, thiadiazolyl, pyrazinyl, pyrimidinyl, indolyl, D Quinolinyl, pyrazolinyl, imidazolinyl, benzimidazolinyl, triazolyl, sangenyl, etc., having at least one selected from nitrogen atom, oxygen atom, sulfur atom, etc. Heteroatoms with 5 to 1 atoms 4, preferably 5 to -9- 200540160 (6) 10 monocyclic or condensed ring aromatic heterocyclic group (the aromatic heterocyclic group, for example, a halogen atom having bromine, chlorine, fluorine, Yao, etc., such as formazan Straight-chain or branched Cl ~ C6 alkyl groups such as alkyl, ethyl, η · propyl, isopropyl, η-butyl, sec-butyl, t-butyl, η-pentyl, n-hexyl, etc .; for example Linear or branched C1 ~ C6 alkoxy groups such as methoxy, ethoxy, η-propoxy, isopropoxy, etc .; for example, methoxymethyl, 1-methoxyethyl, 1-ethoxyethyl (C1 ~ C6 alkoxy)-(C1 ~ C6 alkyl) groups; such as fluoromethyl, diφfluoromethyl, trifluoromethyl, etc. C6 haloalkyl; carboxyl; linear or branched (C1 ~ C6 alkoxy) carbonyl such as methoxycarbonyl, ethoxycarbonyl, etc .; nitro; for example, methoxycarbonylmethyl, 1-methoxycarbonylethyl Or branched (C1 ~ C6 alkoxy) carbonyl- (C1 ~ C6 alkyl), 1-ethoxycarbonylethyl, etc .; substituents such as cyano may also be used); or, for example, hydrofuryl, pyridine Sulfanyl, thiolanyl, thianyl, pyrrolidinyl, There are at least one heteroatomic atom selected from nitrogen atom, oxygen atom, sulfur atom φ represented by indolyl, tetrahydropyridyl, imidazolinyl, piperazinyl, etc., and the number of atoms constituting the ring is 5 to 14, preferably 5 to 10 monocyclic or condensed ring having no aromatic heterocyclic group (which does not have aromatic heterocyclic group, for example, having 1 or more halogen atoms such as bromine, chlorine, fluorine, iodine, etc. ; Such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, t-butyl, n-pentyl, n-hexyl, etc., straight or branched C1 ~ C6 Alkyl; straight or branched C1 ~ C6 alkoxy, such as methoxy, ethoxy, η-propoxy, isopropoxy, etc .; straight or branched, such as methylol, hydroxyethyl, etc. Branch C1 ~ C6 hydroxyalkyl; straight or branched (for example, methoxymethyl, methoxyethyl, ethoxyethyl, etc.) (C1 ~ C6 alkoxy)-(C1 ~ C6 -10- 200540160 (7) alkane Radicals); for example, linear or branched C1 to C6 halogenated alkyl groups such as fluoromethyl, difluoromethyl, trifluoromethyl, etc .; carboxyl groups; or alkali metal salts such as sodium, potassium, and lithium salts thereof, or Alkaline earth metals such as calcium, barium, and magnesium salts Representative metal carboxyl salts; such as linear or branched (C1 ~ C6 alkoxy) carbonyl groups such as methoxycarbonyl, ethoxycarbonyl, etc .; halogen atoms such as bromine, chlorine, fluorine, iodine; nitro; amine ; For example, methylamino, dimethylamino, ethylamino, diethylamine, etc., straight or branched mono- or di (C1 ~ C6 alkyl) amine φ group, such as acetamido Straight or branched (C1 ~ C6 alkyl) carbonylamino groups such as propylamino, butyrylamino, etc .; cyano; methylamidino; such as methylcarbonyl, ethylcarbonyl, etc. C1 ~ C6 alkyl) carbonyl group; for example, aryl carbonyl groups such as phenylfluorenyl, naphthyl fluorenyl and the like having an atomic number of 6 to 14, ideally 6 to 10: for example, pyridinecarbonyl, thiophenecarbonyl, furancarbonyl and the like having 1 Substitution of at least one heteroatom atom selected from nitrogen atom, oxygen atom and sulfur atom, and the number of atoms constituting the ring is 5 to 14, preferably 5 to 10, monocyclic or condensed ring heterocyclic aryl carbonyl group May have an aromatic heterocyclic group with or without φ. The electron withdrawing group represented by R2 in the general formula (1) means an atomic group that attracts an electron by an opponent with an inducing effect. Specifically, for example, a straight chain or a branch having one or more difluoromethyl groups, trifluoromethyl groups, and the like Branched C1 ~ C6 haloalkyl groups; carboxyl groups; for example, linear or branched (C1 ~ C6 alkoxy) carbonyl groups such as methoxycarbonyl, ethoxycarbonyl, etc .; halogen atoms such as bromine, chlorine, fluorine, iodine, etc .; Nitro; Formamyl; Linear or branched (C1 ~ C6 alkyl) carbonyl groups such as methylcarbonyl, ethylcarbonyl, etc .; Aminocarbonyl; Linear or branched (C1) groups such as methylaminocarbonyl ~ C6 alkyl) aminocarbonyl group; for example, di-11-200540160 (8) methylaminocarbonyl group, such as linear or branched di (Cl ~ C6 alkyl) aminocarbonyl group; cyano group; for example, chlorophenyl, Substituents represented by acetophenyl, nitrophenyl, acenaphthyl, etc., in order to induce an atomic group that attracts electrons by an opponent (eg, as described in the above example of an atomic group that attracts electrons by an opponent) Chain or branched C1 ~ C6 haloalkyl; carboxyl group; straight chain or branched (C1 ~ C6 alkoxy) carbonyl; halogen Nitro; formamyl; straight or branched (C1 ~ C6 alkyl) carbonyl; amino carbonyl; straight or branched (C1 ~ C6 alkyl) carbonyl; straight or branched di (C1 ~ C6 Alkyl) aminocarbonyl; monocyclic or condensed C6 to C10 aromatic hydrocarbon groups such as cyano and other atomic groups; cyanopyridyl, chlorophenyl, nitrofuranyl, methylpyridyl, etc. Base, having one or more atomic groups that attract electrons from an opponent with an inducing effect (such as the straight or branched C1 ~ C6 haloalkyl groups described above as examples of atomic groups that attract electrons with an opponent from an inducing effect; carboxyl; linear Or branched (C1 ~ C6 alkoxy) carbonyl; halogen atom; nitro; formamyl: straight or branched (C1 ~ C6 alkyl) carbonyl; aminocarbonyl; straight or branched (C1 ~ C6 Alkyl) aminocarbonyl; linear or branched di (C1 ~ C6 alkyl) aminocarbonyl; atomic groups such as cyano), having 1 to 4 at least one selected from nitrogen, oxygen, and sulfur atoms Heterogeneous atoms include monocyclic or condensed heterocyclic aryl groups having 5 to 14 atoms, preferably 5 to 10, and the like. The substituent represented by R3 in the general formula (1) includes, for example, methyl, ethyl, η · propyl, isopropyl, η-butyl, sec-butyl, t-butyl, and η · Straight-chain or branched C1 ~ C6 alkyl groups such as pentyl, η-hexyl, etc .; C6 ~ C10 aromatic hydrocarbon groups of monocyclic or condensed rings such as phenyl, naphthyl (the aromatic-12-200540160 (9) hydrocarbon group For example, halogen atoms having bromine, chlorine, fluorine, iodine, etc .; for example, methyl, ethyl, η-propyl, isopropyl, η-butyl, sec-butyl, t-butyl, η-pentyl, Straight-chain or branched C1 ~ C6 alkyl groups such as η-hexyl; hydroxyl groups; straight-chain or branched C1 ~ C6 alkoxy groups such as methoxy, ethoxy, η-propoxy, isopropoxy, etc. ; Such as methoxymethyl, 1-methoxyethyl, 1-ethoxyethyl, etc., straight or branched (C1 ~ C6 alkoxy)-(Cl ~ C6 alkyl) groups; such as fluoromethyl, Difluoromethyl, trifluoromethyl, etc. linear or branched C1 ~ C6 halogenated alkyl groups; carboxyl groups; such as methoxycarbonyl, ethoxycarbonyl, etc. (C1 ~ C6 alkoxy) Carbonyl; for example, straight chain of methoxycarbonylmethyl, 1-methoxycarbonylethyl, 1-ethoxycarbonylethyl, etc. Or branched (C1 ~ C6 alkoxy) carbonyl- (C1 ~ C6 alkyl); substituents such as cyano may also be used); for example, furyl, benzofuranyl, pyridyl, thienyl, benzothiophene Base, oxazoline, benzoxazoline, thiazolyl, benzothiazolyl, isoxazoline, thiadiazolyl, pyrazinyl, pyrimidinyl, indolyl, quinolinyl, pyrazole Phenyl, imidazoline, benzimidazoline, triazolyl, triazolyl, etc. are represented by φ and have 1 to 4 at least one hetero atom selected from nitrogen, oxygen, and sulfur atoms, and constitute Single-ring or condensed-ring aromatic heterocyclic group having 5 to 14 ring atoms, preferably 5 to 10 (the aromatic heterocyclic group, such as a halogen atom of bromine, chlorine, fluorine, iodine, etc., such as methyl , Ethyl, η-propyl, isopropyl, butyl, sec-butyl, t-butyl, η-pentyl, η-hexyl, etc., straight or branched C1 to C6 alkyl groups; hydroxyl groups; for example Linear or branched C1 ~ C6 alkoxy groups such as methoxy, ethoxy, η-propoxy, isopropoxy, etc .: e.g. methoxymethyl, 1-methoxyethyl, 1-ethoxyethyl Straight chain or branch (C1 ~ C6 alkoxy)-(C1 ~ C6 alkyl) groups; for example, fluoromethyl, -13- 200540160 (10) straight or branched Cl ~ C6 haloalkyl groups such as difluoromethyl, trifluoromethyl; Carboxy; straight or branched (C1 ~ C6 alkoxy) carbonyl such as methoxycarbonyl, ethoxycarbonyl, etc .; nitro; for example, methoxycarbonylmethyl, 1 · methoxycarbonylethyl, 1-ethoxy Linear or branched (C1 ~ C6 alkoxy) such as carbonylethyl, carbonyl- (C1 ~ C6 alkyl); substituents such as cyano may also be used); or, for example, hydrofuryl, pyranyl, tetrahydro Thioranyl, thianyl, pyrrolidinyl, indolyl, tetrahydropyridyl, imidazolinyl, piperazinyl, etc. have 1 to 4 represented by nitrogen, oxygen, sulfur At least one heteroatomic atom selected for the atom, the number of atoms constituting the ring is 5 to 14, preferably 5 to 10, a monocyclic or condensed ring having no aromatic heterocyclic group (which does not have an aromatic heterocyclic group, For example, it has one or more halogen atoms such as bromine, chlorine, fluorine, iodine, etc., such as methyl, ethyl, η-propyl, isopropyl, η-butyl, sec-butyl, t-butyl, η- Amyl, η-hexane And other straight or branched C1 ~ C6 alkyl groups; hydroxyl groups; for example, methoxy, ethoxy, η-propoxy, isopropoxy, etc. straight or branched C1 ~ C6 alkyloxy groups; Linear or branched (C1 ~ C6 alkoxy)-(C1 ~ C6 alkyl) groups such as oxymethyl, methoxyethyl, and ethoxyethyl; for example, fluoromethyl, difluoromethyl, trifluoro A linear or branched C1 ~ C6 haloalkyl group such as a methyl group; a carboxyl group; or an alkali metal salt thereof such as sodium salt, potassium salt, lithium salt, or an alkaline earth metal salt such as calcium salt, barium salt, or magnesium salt; Carboxylic metal salts; linear or branched (C1 ~ C6 alkoxy) carbonyl groups such as methoxycarbonyl, ethoxycarbonyl, etc .; halogen atoms such as bromine, chlorine, fluorine, iodine, etc .; nitro groups; amine groups; Straight-chain or branched mono- or di- (C 1 to C 6 alkyl) amine groups, such as ethylamino, dimethylamino, ethylamino, diethylamino, etc., such as ethylamino, propylamino Aminobutyrylamido-14- 200540160 (11) Linear or branched (C1 ~ C6 alkyl) carbonylamino; cyano; methylamidino; straight chain such as methylcarbonyl, ethylcarbonyl, etc. Or branched (C1 ~ C6 alkyl) carbonyl For example, the number of atoms constituting a ring such as phenylfluorenyl, naphthyl, and the like is 6 to 14, and an arylcarbonyl group, such as 6 to 10, which has 1 to 4 at least one kind selected from a nitrogen atom, an oxygen atom, and a sulfur atom. It is a monocyclic or condensed ring heterocyclic carbonyl substituent of 5 to 14 atoms, preferably 5 to 10 atoms, and may or may not have an aromatic heterocyclic group. When η in formula (1) is 0, the compound represented by general formula (1) is a sulfide, and when η is 2, the compound represented by general formula (2) is a code. The 5-hydroxy-4-thiomethylpyrazole compound represented by the general formula (1) is a known compound or, for example, the reaction of 5-hydroxypyrazoles with formaldehyde and sulfur compounds described in Reference Examples 1 to 4 described later, Can be easily synthesized. Next, a halogenated difluoromethane represented by the general formula (2) will be described. X in the general formula (2) is an atom such as fluorine, chlorine, bromine, or iodine. Therefore, the halogenated difluoromethane of the general formula (2) that can be used in the present reaction can be exemplified by trifluoromethane, chlorodifluoromethane, bromodifluoromethane, and difluoroiodomethane. Desirable examples include chlorodifluoromethane and bromodifluoromethane, and particularly preferred is chlorodifluoromethane. The molar ratio of the halogenated difluoromethane represented by the general formula (2) can be reacted with the 5-hydroxy-4-thiomethylpyrazole compound represented by the general formula (1) at any molar ratio. . Among them, the molar ratio of the 5-hydroxy-4-thiomethylpyrazole compound represented by the general formula (1) is 1 mole ratio. The halogenated difluoromethane represented by the general formula (2) is usually 0.1 to 10.0 mole ratio. The ideal range is -15-200540160 (12) 1.0 to 5.0 mole ratio, and more preferably 1.3 to 2.2 mole ratio. This reaction can be performed using sodium hydroxide. The sodium hydroxide used in the reaction may be solid sodium hydroxide. Commercially available 96% sodium hydroxide or commercially available granular 99% sodium hydroxide is preferred, especially 9 9 % Sodium hydroxide is more desirable. The amount of sodium hydroxide to be used may be any amount as long as the reaction can proceed sufficiently. Among them, it is 1.0 to 20 moles, preferably 1.5 to 10 moles, and more preferably 2.0 to 3.0 moles, with respect to the 5-hydroxy-4 · thiomethylpyrazole compound represented by 1 mole in general formula (1). Range. In this reaction, the additive is presumed to capture the water produced as a by-product with the reaction in the reaction system. Anhydrous sodium sulfate, calcium chloride, and / or sodium carbonate coexist in the reaction system, especially when the yield is enlarged. Improve stability. In addition, the addition of this additive suppresses the hydrolysis of halogenated difluoromethane, and as a result, the reduction in the amount of halogenated difluoromethane used is related. The amount of the additive to be used is not particularly limited, and it is 0.01 to 20 mol, and preferably 0.1 to 10 mol relative to the 5-hydroxy-4-thiomethylpyrazole compound represented by the general formula (1). More preferably, a range of 0.2 to 5.0 mol can exhibit sufficient effects. From the observation of the present inventors, the additive is presumed to be a job for capturing water by-produced with the reaction in the reaction system, and a job for capturing water by-produced with the reaction in the reaction system may use substances other than those exemplified above. These substances. This reaction can be carried out, for example, in the presence of a bis (C1 to C3 alkyl) ketone such as acetone or methyl ethyl ketone; or a (C1 to C3 alkyl) nitrile such as acetonitrile or propiononitrile. Usually, the reaction solvent can also be used for the reaction. The reaction system can fully stir -16-200540160 (13) The excess amount is mixed, and it is usually 0.05 ~ 10 L compared with 1 mole of the raw material compound represented by general formula (1). It is preferably 0.3 to 5 L, and more preferably 0.5 to 2 L. Use bis (C1 ~ C3 alkyl) ketone, (C1 ~ C3 alkyl) nitrile alone, or a solvent that does not hinder the reaction, such as aromatic hydrocarbons that can be mixed with toluene, xylene, chlorobenzene, etc .; dichloromethane, Halogenated aliphatic hydrocarbons such as chloroform; ether solvents such as diethyl ether and diisopropyl ether; and aliphatic φ hydrocarbons such as pentane and hexane are used. However, the mixing ratio of di (C1 ~ C3 alkyl) ketone and (C1 ~ C3 alkyl) nitrile is extremely reduced, and the reaction rate decreases as the reaction rate is not ideal. The mixing ratio (capacity) relative to the mixed solvent of aromatic hydrocarbons and the like Ratio) is 1 or more (that is, the mixed solvent of aromatic hydrocarbons and the like is equal or more), it is desirable to mix di (C1 ~ C3 alkyl) ketone and (C1 ~ C3 alkyl) nitrile with a solvent that does not hinder the reaction When used in combination, the amount used is within the above-mentioned range (relative to the starting compound 1 mol di (C1 ~ C3 alkyl) ketone, (C1 ~ C3 alkyl) nitrile) represented by the general formula (1), and is usually 0 · 〇. 1 ~ 10 L, the ideal φ is 0.3 ~ 5L, more preferably 0.5 ~ 2L). The total solvent amount is preferably an amount sufficient for the reaction system to be sufficiently agitated, and is usually from 0.001 to L, and more preferably from 0.5 to 2 L, relative to the raw compound 1 mole represented by the general formula (1). The reaction temperature of this reaction must be carried out at -10 ° C to 35 ° C, and the reaction rate is preferably 0 t to 10 ° C. The reaction time of this reaction is not particularly limited, and the reaction rate varies depending on the introduction rate of the halogenated difluoromethane represented by the general formula (2). The reaction is usually completed within 1 to 30 hours. -17- 200540160 (14) There is no particular limitation on the order and method of adding each component to the reaction. A suitable example is to add an alkali to the organic layer, add a raw material compound represented by the general formula (1) to a suspension state, and then introduce a halogenated difluoromethane represented by the general formula (2) to react to obtain a general compound. Method of the product represented by formula (3). According to this reaction, a 5-hydroxy-4-thiomethylpyridine compound represented by the general formula (1) and a halogenated difluoromethane represented by the general formula (2) are used in the presence of sodium hydroxide φ. (C1 ~ C3 alkyl) ketones and (C1 ~ C3 alkyl) nitriles generate 5-difluorinated methoxy-4-thiomethylpyrazole compounds represented by the general formula (3), and are used as medicine, Compounds of pesticide intermediates. [Embodiment] The following describes the manufacturing method of the present invention with reference examples and examples. The present invention is not limited to the examples. φ (Reference Example 1) 3-[(5-hydroxy-1-methyl · 3-trifluoromethylpyrazole-4- 醯) -methylsulfan 4,5-dihydro-5,5-dimethyl Synthesis of diisoxazole 5-hydroxy-1 · methyl-3-trifluoromethanepyrazole 1.7 g (10 mmol) and sodium hydroxide K6 g (40 mmol) solvent in 10 ml of water. After the solution was stirred at room temperature, 1.7 g (20 mmol) of a 35% aqueous formaldehyde solution (35% formalin solution) was added dropwise, and the mixture was stirred at the same temperature for 1 hour. Here, 10 ml of an aqueous solution of [5,5-dimethyl (4,5-dihydroisoD-oxazol-3-])] thiocarboxamidine hydrochloride (2.1 g (10 mmol)) was added dropwise. 'Stir for 2 hours. After the reaction, drip at 35 ° /. 5.0 g (50 mmol) of hydrochloric acid. The precipitated crystals were suction-filtered -18- 200540160 (15) and washed twice with 5 ml of water. Drying with a warm air dryer gave 2.5 g (yield 80.1%) of the title compound as pale yellow crystals. The obtained crystals were recrystallized from a η-hexane / 2-propanol mixed solvent to obtain white crystals. ] H-NMR 値 (3 00 MHz, MeOH-d4): 〇 = 4.88 (br, 1H), 4.08 (s, 2H), 3.64 (s, 3H), 2.91 (s, 2H),] 39 (s , 6H) ppm o

LC ~ MS (El) ·· m / z = 3 09 (M + ) » 17 7 (base) φ 融點:1 1 5 - 1 1 6 °C (參考例2) 5·羥基-1-甲基-4-甲基硫甲基-3-三氟甲基吡唑 的合成 5-羥基-1-甲基-3-三氟甲烷吡唑1.7 g (10 mmol)與氫 氧化鈉〇·6 g (15 mmol)溶劑於10 ml水。該溶液於室溫 攪拌後,滴入35%甲醛水溶液 (35%福馬林溶液)1.7 g (2 0 mmol),於同溫攪拌1小時。於室溫滴入10%鈉硫甲 φ 醇金屬水溶液7.1 g(l〇mmol),攪拌6小時。反應後,滴 入3 5%鹽酸5.0 g (50 mmol)。析出之結晶吸濾後,以5 ml 水洗淨2次。以溫風乾燥機乾燥,得到主題化合物1.6 g ( 產率72.7 %)的淡黃色結晶。所得之結晶,以水-甲醇 混合溶劑再結晶,得到白色結晶。 iH-NMR 値 (300 MHz,MeOH-d4) : a = 4.86 (br,lH),3.64 (s,3H),3.56 (s,2H),2.02 (s,3H) ppm。 LC - MS (El) ·· m / z = 226 (M + ),179 (base)LC ~ MS (El) · m / z = 3 09 (M +) »17 7 (base) φ Melting point: 1 1 5-1 1 6 ° C (Reference Example 2) 5 · Hydroxy-1-methyl Synthesis of 4-methylthiomethyl-3-trifluoromethylpyrazole 5-hydroxy-1-methyl-3-trifluoromethanepyrazole 1.7 g (10 mmol) and sodium hydroxide 0.6 g ( 15 mmol) of solvent in 10 ml of water. After the solution was stirred at room temperature, 1.7 g (20 mmol) of a 35% formaldehyde aqueous solution (35% formalin solution) was added dropwise, and the mixture was stirred at the same temperature for 1 hour. At room temperature, 7.1 g (10 mmol) of a 10% sodium sulfur methyl alkoxide aqueous metal solution was added dropwise, and the mixture was stirred for 6 hours. After the reaction, 5.0 g (50 mmol) of 3 5% hydrochloric acid was added dropwise. The precipitated crystals were filtered with suction and washed twice with 5 ml of water. Drying with a warm air dryer gave 1.6 g (yield 72.7%) of the title compound as pale yellow crystals. The obtained crystals were recrystallized from a water-methanol mixed solvent to obtain white crystals. iH-NMR 値 (300 MHz, MeOH-d4): a = 4.86 (br, 1H), 3.64 (s, 3H), 3.56 (s, 2H), 2.02 (s, 3H) ppm. LC-MS (El) · m / z = 226 (M +), 179 (base)

融點:123 - 124°C -19· 200540160 (16) (參考例3) 4-[(5-羥基-卜甲基-3-三氟甲基吡唑-4-醯)·甲基 磺醯]甲苯的合成Melting point: 123-124 ° C -19 · 200540160 (16) (Reference Example 3) 4-[(5-hydroxy-p-methyl-3-trifluoromethylpyrazole-4- 醯) · methylsulfonium] toluene Synthesis

5-羥基-1-甲基-3-三氟甲烷吡唑8.3 g (50 mmol)與氫 氧化鈉3.0 g ( 7 5 m m ο 1)溶劑於5 0 m 1水。該溶液於室溫 攪拌後,滴入35%甲醛水溶液 (35%福馬林溶液)8·5 g (100 mmol),於同溫攪拌1小時。於此,於室溫投入甲苯 亞磺鈉9.0 g (50 mmol),攪拌2小時。反應後,滴入35% 鹽酸25.0 g (2 5 0 mmol),更加入水1〇〇 ml。析出之結晶吸 濾後,以20 ml水洗淨2次。以溫風乾燥機乾燥,得到主 題化合物14.0 g (產率83.8%)的白色結晶。 j-NMR 値(3 00 MHz,MeOH-d4) ·· σ =7.62 (d ; J =8.4 Hz,2H),7.39 (d ; J = 8.4 Hz,2H),4·85 (br,lH) ,4.32 (s,2H),3.63 (s,3H), 2 · 4 4 (s,3 H) ppm 〇 LC - MS (El) : m / z = 3 34 (M + ),179 (base)5-Hydroxy-1-methyl-3-trifluoromethanepyrazole 8.3 g (50 mmol) and sodium hydroxide 3.0 g (7.5 m m ο 1) were dissolved in 50 m 1 of water. After the solution was stirred at room temperature, 8.5 g (100 mmol) of a 35% formaldehyde aqueous solution (35% formalin solution) was added dropwise, and the mixture was stirred at the same temperature for 1 hour. Here, 9.0 g (50 mmol) of sodium toluenesulfinate was added at room temperature and stirred for 2 hours. After the reaction, 25.0 g (2 50 mmol) of 35% hydrochloric acid was added dropwise, and 100 ml of water was further added. The precipitated crystals were filtered with suction and washed twice with 20 ml of water. Drying with a warm air dryer gave 14.0 g (yield 83.8%) of the title compound as white crystals. j-NMR 値 (3 00 MHz, MeOH-d4) · σ = 7.62 (d; J = 8.4 Hz, 2H), 7.39 (d; J = 8.4 Hz, 2H), 4.85 (br, 1H), 4.32 (s, 2H), 3.63 (s, 3H), 2 · 4 4 (s, 3 H) ppm 〇 LC-MS (El): m / z = 3 34 (M +), 179 (base)

融點:1 3 5 °C (參考例4) 4-[3-氰基-5-羥基-1-苯基吡唑-4-醯]-甲基磺基] 甲苯的合成 5-羥基-1-甲基-3-三氟甲烷吡唑1.8 g (10 mmol)與氫 氧化鈉0.6 g (15 mmol)溶劑於1〇 ml水。該溶液於室溫 攪拌後,滴入35%甲醛水溶液(35%福馬林溶液)1.7 g ( 20 mmol),於同溫攪拌1小時。於此,於室溫投入甲苯亞 磺酸鈉1·8 g (10 mmol)’攪拌2小時。反應後’滴入35% 鹽酸5.0 g (50 mmol),更加入20 ml水。析出之結晶吸濾 -20- 200540160 (17) 後,以2 0 ml水洗淨2次。以溫風乾燥機乾燥,得到主題 化合物3.0 g (產率85.7%)的淡黃色結晶。 j-NMR 値(300 MHz,MeOH-d4) : σ =7.4 - 7.7 (m ;9H),4.86 (s,lH),4·40 (s,2H),2.46 (s,3H) ppm LC - MS (El) : m / z = 3 5 3 (M + ),197 (base)Melting point: 1 3 5 ° C (Reference Example 4) Synthesis of 4- [3-cyano-5-hydroxy-1-phenylpyrazole-4- 醯] -methylsulfo] toluene 5-hydroxy-1 -1.8 g (10 mmol) of methyl-3-trifluoromethanepyrazole and 0.6 g (15 mmol) of sodium hydroxide in 10 ml of water. After the solution was stirred at room temperature, 1.7 g (20 mmol) of a 35% aqueous formaldehyde solution (35% formalin solution) was added dropwise, and the mixture was stirred at the same temperature for 1 hour. Here, 1.8 g (10 mmol) of sodium toluenesulfinate was added at room temperature and stirred for 2 hours. After the reaction, 5.0 g (50 mmol) of 35% hydrochloric acid was added dropwise, and 20 ml of water was further added. The precipitated crystals were filtered with suction -20- 200540160 (17), and washed twice with 20 ml of water. Drying with a warm air dryer gave 3.0 g (yield 85.7%) of the title compound as pale yellow crystals. j-NMR 値 (300 MHz, MeOH-d4): σ = 7.4-7.7 (m; 9H), 4.86 (s, 1H), 4.40 (s, 2H), 2.46 (s, 3H) ppm LC-MS (El): m / z = 3 5 3 (M +), 197 (base)

融點:2 1 4 °C φ 實施例l:3-[5-二氟甲氧基-1-甲基-3-三氟甲基吡唑-4-醯 ]-甲基硫]_4,5-二氫-5,5-二甲基異噁唑的合成 於100 ml乙腈,添加由參考例1合成之 3-[(5-羥基-1-甲基-3-三氟甲基吡唑-4-醯)·甲基硫]-4,5-二氫-5,5-二甲 基異噁唑33.2 g (純度93.3 %,0·1 mol)與99%氫氧化鈉 12.0 g (0.3 mol),於室溫攪拌1小時。將該懸浮液冰冷, 保持於5〜15 °C的範圍內後,於4小時時間導入17.3 g (0.2mol)氯二氟甲烷,於同溫度範圍反應5小時。反應終 Φ 了後,加入100 ml甲苯、50 ml水及10 ml 35°/。鹽酸,分 取有機層。水層以50 ml再萃取後,合倂之有機層以50 ml水、20 ml飽和食鹽水的順序洗淨。將所得之有機層 以硫酸鈉乾燥,由餾去溶劑,得到表題化合物38.0 g (純 度85%,純分產率90%)的赤褐色液體。將其以矽膠柱光 議法.(展開溶劑;己烷/醋酸乙酯 = 4/1)精製,得 表題化合物22.6白色結晶。 4 - NMR 値(3 00 MHz,CDC13) ·· σ = 6.72 (t ; J = 72Hz,1H),4.17 (s,2H),3.80 (s,3H),2.77 (s,2H),1·40 21 - 200540160 (18) (s,6H) GC - MS (El) : m / z = 3 5 9 (M + ),179 (base)Melting point: 2 1 4 ° C φ Example 1: 3- [5-Difluoromethoxy-1-methyl-3-trifluoromethylpyrazole-4- 醯] -methylsulfide] _4,5 -Synthesis of dihydro-5,5-dimethylisoxazole in 100 ml of acetonitrile, and 3-[(5-hydroxy-1-methyl-3-trifluoromethylpyrazole) synthesized in Reference Example 1 was added 4- 醯) · methylsulfur] -4,5-dihydro-5,5-dimethylisoxazole 33.2 g (purity 93.3%, 0.1 mol) and 99% sodium hydroxide 12.0 g (0.3 mol ), And stirred at room temperature for 1 hour. After the suspension was ice-cooled and kept in the range of 5 to 15 ° C, 17.3 g (0.2 mol) of chlorodifluoromethane was introduced over a period of 4 hours and reacted in the same temperature range for 5 hours. After the reaction is completed, add 100 ml toluene, 50 ml water and 10 ml 35 ° /. Hydrochloric acid, and the organic layer was separated. After the aqueous layer was re-extracted at 50 ml, the combined organic layer was washed in the order of 50 ml of water and 20 ml of saturated saline. The obtained organic layer was dried over sodium sulfate, and the solvent was distilled off to obtain 38.0 g of the title compound (purity: 85%, purity: 90%) as a reddish brown liquid. The product was purified by silica gel column chromatography (developing solvent; hexane / ethyl acetate = 4/1) to obtain the title compound 22.6 as white crystals. 4-NMR 値 (3 00 MHz, CDC13) ·· σ = 6.72 (t; J = 72Hz, 1H), 4.17 (s, 2H), 3.80 (s, 3H), 2.77 (s, 2H), 1.40 21-200540160 (18) (s, 6H) GC-MS (El): m / z = 3 5 9 (M +), 179 (base)

融點:47 - 48 °C 於以下實施例2〜5,使用實施例丨所得之化合物爲 標準品之內部標準分析法(內部標準;η -辛基苯)算出產 φ 實施例2 : 3-[(5-二氟甲氧-1-甲基-3·三氟甲基吡唑醯)-甲硫]-4,5-二氫-5,5-二甲異噁唑的產率確認 於乙醯腈20 ml,添加η·辛基苯g (內部標準物質) ,參考例1合成之3·[(5·羥基-1-甲基-3·三氟甲基吡唑-4· 醯)·甲基硫]-4,5 -二氫-5,5 -二甲基異噁唑1.7 g (純度 93·3%,〇·〇1 mmol)及 99%氫氧化鈉 1.2 g (〇·3 mmol), 於室溫攪拌1小時。將該懸浮液冰冷,保持於0〜i 〇〇c的 範圍內後,使用氣球將過量的氯二氟甲烷導入,由吹入開 • 始1小時後,抽取反應液樣本,使用氣相色譜儀依內部標 準分析法算出反應產率的結果,產率爲89%。 實施例3〜5及比較例1〜9 如實施例2的同樣操作,於各種溶劑中(總量爲2 0 ml)進行反應。結果彙集如表1。於比較例的反應,任一 者均添加相關移動觸媒四丁基溴化銨〇·〇5 g。又,(表1) 中的溶劑項以「v ·· v」表示容量比。 -22- 200540160 (19) [表1]Melting point: 47-48 ° C In the following Examples 2 to 5, the internal standard analysis method (internal standard; η-octylbenzene) of the compound obtained in Example 丨 as a standard was used to calculate the production φ Example 2: 3- The yield of [(5-difluoromethoxy-1-methyl-3 · trifluoromethylpyrazolidine) -methylthio] -4,5-dihydro-5,5-dimethylisoxazole was confirmed at 20 ml of acetonitrile, η · octylbenzene g (internal standard material), 3 · [(5 · hydroxy-1-methyl-3 · trifluoromethylpyrazole-4 ··) synthesized in Reference Example 1 Methylsulfur] -4,5-dihydro-5,5-dimethylisoxazole 1.7 g (purity 93.3%, 0.001 mmol) and 99% sodium hydroxide 1.2 g (0.3 mmol), and stirred at room temperature for 1 hour. After the suspension was kept cold in the range of 0 to 100 ° C, an excessive amount of chlorodifluoromethane was introduced using a balloon, and after 1 hour from the start of blowing, a sample of the reaction solution was taken and a gas chromatograph was used. The reaction yield was calculated according to an internal standard analysis method, and the yield was 89%. Examples 3 to 5 and Comparative Examples 1 to 9 In the same manner as in Example 2, the reaction was performed in various solvents (total amount: 20 ml). The results are summarized in Table 1. In the reaction of the comparative example, 0.05 g of tetrabutylammonium bromide, a related mobile catalyst, was added to each of them. In addition, the solvent term in (Table 1) indicates the capacity ratio by "v · · v". -22- 200540160 (19) [Table 1]

實施例 編號 溶劑 反應 時間 產率 (%) •—---- 原料殘率 (%) 2 乙醯腈 1 89 0 3 丙酮 1 86 0 4 乙醯腈:甲苯 (v ·· v = 1 : 1) 5 89 0 5 丙酮:甲苯 (v · v = 1 · 1) 3 93 0 比較例1 甲苯:水 (v : v=l : 1) 20 28 15 比較例2 甲苯 20 50 23 比較例3 氯苯 20 33 5 5 比較例4 二甲氧基乙烷 20 68 0 比較例5 四氫呋喃 20 69 6 比較例6 二異丙醚 20 2 77 比較例7 1-甲基-2-吡咯基二酮 20 72 11 比較例8 2-丙醇 3 10 11 比較例9 _4-甲基-2-戊酮 20 41 27 (比較例10) . 除了實施例2的99 %氫氧化鈉以99%氫氧化鉀取代以 外(使用相同莫耳數),與實施例2進行同樣操作反應。 -23- 200540160 (20) 結果吹入開始1小時後的分析,僅生成目的物1 0%,原料 亦已消失,殘留者爲分解物。 (比較例11) 除了實施例2的氫氧化鈉以氫氧化鉀取代以外(使用 相同莫耳數),與實施例2進行同樣操作反應。結果吹入 開始24小時後的分析,僅生成目的物1 %,殘留者爲原料 實施例6 : 5-二氟甲氧基-1-甲基-4-甲基硫甲基-3·三氟甲 基吡唑的合成法 於乙醯腈10 ml,參考例2合成之5-羥基-1-甲基-4-甲基硫甲基-3-三氟甲基吡唑1.2 g (5 mmol)及99%氫氧 化鈉0 · 6 g (1 5 m m ο 1 ),於室溫攪拌1小時。將該懸浮液冰 冷,保持於〇〜10°C的範圍內後,使用氣球將過量的氯二 | 氟甲院導入,由吹入開始1小時後,拆卸氣球,於反應液 加入20 ml水,醋酸乙酯20 ml,分取有機層。更將水層 以2 0ml的酯酸乙酯再萃取,合倂有機層以1〇 ml水及10 ml飽和鹽水順序洗淨。所得有機層以硫酸鈉乾燥,將溶 劑餾去,得到表題化合物1.2 g (產率88%)的淡黃色液體 〇 W-NMR 値(3 00 MHz,CDC13 ) : 〇 =6.82 (t ; J = 72.6 Ηζ,1Η),3.82 (s,3H),3.61 (s,2H),2.09 (s,3H) GC - MS (El) ·· m / z = 276 (M + ),179 (base) -24 - 200540160 (21) 實施例7: 4-[(5-二氟甲氧基-1-甲基-3-三氟甲基吡唑-4•醯 )-甲基磺醯]甲苯的合成法 於乙醯腈10 ml,參考例3合成之4-[(5·羥基-1-甲基-3-三氟甲基吡唑-4-醯)-甲基磺醯]甲苯1.7 g (5 mmol)及 9 9 %氫氧化鈉0 · 6 g (1 5 mm ο 1 ),於室溫攪拌1小時。將該 懸浮液冰冷,保持於0〜1 0 °C的範圍內後,使用氣球將過 量的氯二氟甲烷導入,由吹入開始1小時後,拆卸氣球, φ 於反應液加入20 ml水,醋酸乙酯20 ml,分取有機層。 更將水層以20ml的酯酸乙酯再萃取,合倂有機層以1〇 mi 水及1 〇 ml飽和鹽水順序洗淨。所得有機層以硫酸鈉乾燥 ,將溶劑餾去,得到表題化合物2.1 g (產率99%)的淡黃 色結晶。所得之結晶以η-己烷-2-丙醇再結晶,得到白色 結晶。 4 - NMR 値(3 00 MHz,CDC13) : a =7.70 (d ; J = 8.4Hz,2H) » 7.35 (d ; J = 8.4Hz,2H) > 6.99 (t ; J = 72.4Hz • ,1H),4.12 (s,2H),3.85 (s,3H),2.46 (s,3H) GC - MS (El) : m / z = 384 (M + ),229 (base) 實施例8: 4-[(3-氰基-5-二氟甲基-1-苯基吡唑·4-醯)甲基 磺醯基]甲苯的合成 於乙醯腈1〇 ml,參考例4合成之4·[3 -氰基-5-經基· 1-苯基吡唑-4-醯]•甲基磺基]甲苯丨·8 g (5 mmol)及99% 氫氧化鈉〇·6 g (15 mmol),於室溫攪拌1小時。將該懸浮 液冰冷,保持於〇〜1 〇 °C的範圍內後’使用氣球將過量的 -25- 200540160 (22) 氯二氟甲烷導入,由吹入開始丨小時後,拆卸氣球,於反 應液加入2 0 m 1水,醋酸乙酯2 0 m 1,分取有機層。更將 水層以酯酸乙酯再萃取,合倂有機層以10 ml水及10 ml 飽和鹽水順序洗淨。所得有機層以硫酸鈉乾燥,將溶劑餾 去,得到表題化合物1.8 g (產率88%)的淡黃色結晶。所 得之結晶以η-己烷-2-丙醇再結晶,得到白色結晶。 !H - NMR 値(300 MHz,CDC13) : σ =7.75 (d ; • J = 8.4Hz,2H),7·6 -7.4 (m,5H),7.41 (t ; J = 8·4Ηζ,2H) ,6.87 (t ; J = 72.4Hz,lH),4.31 (s,2H),2.49 (s,3H) GC - MS (El) : m / z = 403 (M + ),248 (base) 實施例9 :使用添加劑碳酸鈉時的3-[(5-二氟甲氧-1-甲基-3-三氟甲基吡唑-4-醯)-甲硫]-4,5-二氫-5,5-二甲異噁唑的 合成 於乙醯腈1,〇〇〇 m卜添加參考例合成之3-[(5·羥基-1-φ 甲基-3-三氟甲基吡唑-4-醯)-甲基硫]-4,5·二氫-5,5-二甲基 異噁唑320g (純度96.8°/〇,lmol)及99%氫氧化鈉12〇8 (3 mol)與碳酸鈉53 g (0.5莫耳),於室溫攪拌1小時。 將該懸浮液冰冷,保持於5〜1 5 °C的範圍內後,於4小時 導入氯二氟甲烷130 g (1.5 mol),於同溫度範圔反應6小 時。反終了後,加入1,〇〇〇 ml水,分取有機層。水層以 300 ml乙醯腈再萃取後,合倂有機層。該有機層中使用氣 乳色譜儀依內部標準分析法算出反應產率的結果,產率爲 9 1%。 -26- 200540160 (23) 【產業上之利用領域】 本發明提供 5-二氟化甲氧基-4-硫甲 穎工業的製造方法,依本發明使用容易合 硫甲基吡唑與鹵化二氟甲烷爲原料,簡便 化甲氧基-4-硫甲基吡唑化合物。本發明的 高產率得到醫藥及農藥的製造中間物有用 基-4-硫甲基吡唑化合物。 又,本發明引用2004年4月28日申 請2004- 1 32764號的說明書、專利申請的 的全內容,溶入作爲本發明說明書的揭示 基吡唑化合物新 、成之5-羥基-4-操作製造5-二氟 原料分解少,可 的5-二氟化甲氧 請的日本專利申 範圍及發明摘要Example No. Solvent reaction time yield (%) • —---- Residue of raw material (%) 2 Acetonitrile 1 89 0 3 Acetone 1 86 0 4 Acetonitrile: toluene (v · · v = 1: 1 ) 5 89 0 5 Acetone: Toluene (v · v = 1 · 1) 3 93 0 Comparative Example 1 Toluene: Water (v: v = 1: 1) 20 28 15 Comparative Example 2 Toluene 20 50 23 Comparative Example 3 Chlorobenzene 20 33 5 5 Comparative example 4 Dimethoxyethane 20 68 0 Comparative example 5 Tetrahydrofuran 20 69 6 Comparative example 6 Diisopropyl ether 20 2 77 Comparative example 7 1-Methyl-2-pyrrolyldione 20 72 11 Comparative Example 8 2-propanol 3 10 11 Comparative Example 9 _4-methyl-2-pentanone 20 41 27 (Comparative Example 10). Except that 99% sodium hydroxide of Example 2 was replaced with 99% potassium hydroxide ( The same mole number was used, and the same reaction was performed as in Example 2. -23- 200540160 (20) Results After 1 hour from the start of the blow-in analysis, only 10% of the target substance was formed, the raw materials had disappeared, and the remaining substances were decomposed products. (Comparative Example 11) A reaction was performed in the same manner as in Example 2 except that the sodium hydroxide of Example 2 was replaced with potassium hydroxide (using the same mole number). As a result, analysis was performed 24 hours after the start of blowing, and only 1% of the target substance was formed, and the remainder was the raw material. Example 6: 5-Difluoromethoxy-1-methyl-4-methylthiomethyl-3 · trifluoro Synthesis of methylpyrazole in 10 ml of acetonitrile, 5-hydroxy-1-methyl-4-methylthiomethyl-3-trifluoromethylpyrazole synthesized in Reference Example 2 1.2 g (5 mmol) And 99% sodium hydroxide 0.6 g (15 mm ο 1), and stirred at room temperature for 1 hour. After the suspension was ice-cooled and kept in the range of 0 to 10 ° C, an excessive amount of chlorodi | fluroin was introduced using a balloon. After 1 hour from the start of blowing, the balloon was disassembled and 20 ml of water was added to the reaction solution. 20 ml of ethyl acetate, and the organic layer was separated. Furthermore, the aqueous layer was re-extracted with 20 ml of ethyl acetate, and the combined organic layer was washed with 10 ml of water and 10 ml of saturated saline in this order. The obtained organic layer was dried over sodium sulfate, and the solvent was distilled off to obtain 1.2 g (yield 88%) of the title compound as a pale yellow liquid. OW-NMR 値 (3 00 MHz, CDC13): 〇 = 6.82 (t; J = 72.6 Ηζ, 1Η), 3.82 (s, 3H), 3.61 (s, 2H), 2.09 (s, 3H) GC-MS (El) · m / z = 276 (M +), 179 (base) -24- 200540160 (21) Example 7: Synthesis of 4-[(5-difluoromethoxy-1-methyl-3-trifluoromethylpyrazole-4 • 醯) -methylsulfonium] toluene 10 ml of acetonitrile, 1.7 g (5 mmol) of 4-[(5 · hydroxy-1-methyl-3-trifluoromethylpyrazole-4- 醯) -methylsulfonium] toluene synthesized in Reference Example 3 and 99% sodium hydroxide 0.6 g (15 mm ο 1), and stirred at room temperature for 1 hour. After the suspension was kept cold at a temperature of 0 to 10 ° C, an excessive amount of chlorodifluoromethane was introduced using a balloon. After 1 hour from the start of blowing, the balloon was disassembled, and 20 ml of water was added to the reaction solution. 20 ml of ethyl acetate, and the organic layer was separated. The aqueous layer was re-extracted with 20 ml of ethyl acetate, and the combined organic layer was washed with 10 mi of water and 10 ml of saturated saline in this order. The obtained organic layer was dried over sodium sulfate, and the solvent was distilled off to obtain 2.1 g (yield: 99%) of the title compound as pale yellow crystals. The obtained crystals were recrystallized from? -Hexane-2-propanol to obtain white crystals. 4-NMR 値 (3 00 MHz, CDC13): a = 7.70 (d; J = 8.4Hz, 2H) »7.35 (d; J = 8.4Hz, 2H) > 6.99 (t; J = 72.4Hz •, 1H ), 4.12 (s, 2H), 3.85 (s, 3H), 2.46 (s, 3H) GC-MS (El): m / z = 384 (M +), 229 (base) Example 8: 4- [ (3-Cyano-5-difluoromethyl-1-phenylpyrazole · 4- 醯) methylsulfonyl] toluene was synthesized in 10 ml of acetonitrile, and 4 in Synthesis of Reference Example 4 [3 -Cyano-5-acyl · 1-phenylpyrazole-4- 醯] • methylsulfo] toluene · 8 g (5 mmol) and 99% sodium hydroxide 0.6 g (15 mmol), Stir at room temperature for 1 hour. The suspension was cooled with ice and kept in the range of 0 to 10 ° C. '-25- 200540160 (22) chlorodifluoromethane was introduced in excess using a balloon, and the balloon was disassembled and reacted after 1 hour from the start of blowing. 20 ml of water and 20 ml of ethyl acetate were added to the solution, and the organic layer was separated. The aqueous layer was re-extracted with ethyl ester, and the combined organic layer was washed with 10 ml of water and 10 ml of saturated saline in this order. The obtained organic layer was dried over sodium sulfate, and the solvent was distilled off to obtain 1.8 g (yield 88%) of the title compound as pale yellow crystals. The obtained crystals were recrystallized from? -Hexane-2-propanol to obtain white crystals. ! H-NMR 値 (300 MHz, CDC13): σ = 7.75 (d; • J = 8.4Hz, 2H), 7.6-7.4 (m, 5H), 7.41 (t; J = 8 · 4Ηζ, 2H) , 6.87 (t; J = 72.4Hz, 1H), 4.31 (s, 2H), 2.49 (s, 3H) GC-MS (El): m / z = 403 (M +), 248 (base) Example 9 : 3-[(5-difluoromethoxy-1-methyl-3-trifluoromethylpyrazole-4- 醯) -methylsulfide] -4,5-dihydro-5, when using the additive sodium carbonate, Synthesis of 5-dimethylisoxazole from acetonitrile 1,000,000. Addition of 3-[(5-hydroxy-1-φmethyl-3-trifluoromethylpyrazole-4-醯) -Methylsulfur] -4,5 · Dihydro-5,5-dimethylisoxazole 320g (purity 96.8 ° / 〇, 1mol) and 99% sodium hydroxide 1208 (3 mol) and carbonic acid 53 g (0.5 mol) of sodium were stirred at room temperature for 1 hour. After the suspension was kept cold at 5 to 15 ° C, the suspension was introduced with 130 g (1.5 mol) of chlorodifluoromethane over 4 hours, and reacted at the same temperature range for 6 hours. After the reaction was completed, 1,000 ml of water was added, and the organic layer was separated. After the aqueous layer was re-extracted with 300 ml of acetonitrile, the organic layer was combined. The organic layer was analyzed for the reaction yield using a gas chromatograph in accordance with an internal standard analysis method. The yield was 91%. -26- 200540160 (23) [Industrial application field] The present invention provides a 5-difluorinated methoxy-4-thiomethanine manufacturing method. According to the present invention, thiomethylpyrazole and halogenated dihalide are easily used. As a raw material, fluoromethane is used to simplify methoxy-4-thiomethylpyrazole compounds. The intermediates useful in the manufacture of pharmaceuticals and pesticides are obtained in the high yield of the present invention as a 4-thiomethylpyrazole compound. In addition, the present invention refers to the entire specification of the application No. 2004-1 32764 dated April 28, 2004, and the entire contents of the patent application, and is incorporated into the 5-hydroxy-4-operation of the novel pyrazolium compound as the disclosure of the present specification. 5-Difluoride raw material has less decomposition, and 5-difluoromethoxy is available. Japanese Patent Application Scope and Summary of Invention

-27--27-

Claims (1)

200540160 (1) 十、申請專利範圍 1· 一種如一般式(3)之5-二氟化甲氧基-4-硫甲基吡 哗化合物之製造方法,其特徵爲將一般式(1)200540160 (1) 10. Scope of patent application 1. A method for producing a 5-difluoromethoxy-4-thiomethylpyrazol compound such as the general formula (3), which is characterized in that the general formula (1) (式中’ R!爲烷基、可具有取代基之芳香族烴基或可具有 取代基之雜環基,R2爲電子收回基、R3爲烷基、可具有 取代基之芳香族烴基或可具有取代基之雜環基,η爲〇或 2) 所示之5-羥基-4-硫甲基吡唑化合物,與一般式(2) CHF2 X (2)(Where 'R! Is an alkyl group, an aromatic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R2 is an electron recovery group, R3 is an alkyl group, an aromatic hydrocarbon group which may have a substituent or may have A heterocyclic group of a substituent, η is 0 or 2) a 5-hydroxy-4-thiomethylpyrazole compound represented by the formula (2) CHF2 X (2) (式中,X爲鹵原子) 所示之鹵化二氟甲烷,於二(C1〜C3烷基)酮或(C1〜 e3烷基)腈、及氫氧化鈉的存在下反應者 R2 厂 S{0)n_R3 )Τ\ ν、ν 入〇chf2 I Rl (3) (式中Ri、R2、R3及n意義與上述相同)。 -28- 200540160 (2) 2. 如申請專利範圍第1項之5-二氟化甲4 耻哩化合物之製造方法,其中一般式(2)中 〇 3. 如申請專利範圍第1或2項之5_二氟伯 甲基舭哩化合物之製造方法,其中者。 4 ·如申請專利範圍第1或;2項之5 _二氣介 甲基吡唑化合物之製造方法,其中η爲2者。 5 ·如申g靑專利範圍第1至4項中任一項之 氧基-4-硫甲基吡唑化合物之製造方法,其中β 水捕集作用之添加劑存在下進行者。 6·如申請專利範圍第5項之5 -二氟化甲氧 吡锉化合物之製造方法,其中具有水捕集水作 爲選自無水硫酸鈉、氯化鈣、及碳酸鈉所成群 者0 I基-4-硫甲基 之X爲氯者 ,甲氧基-4-硫 甲氧基-4 -硫 5-二氟化甲 〔應係於具有 基-4-硫甲基 用之添加劑 之至少1種(In the formula, X is a halogen atom.) The halogenated difluoromethane shown in the presence of bis (C1 ~ C3 alkyl) ketone or (C1 ~ e3 alkyl) nitrile, and sodium hydroxide is the reactor R2 plant S { 0) n_R3) T \ ν, ν into 0chf2 I Rl (3) (where Ri, R2, R3 and n have the same meaning as above). -28- 200540160 (2) 2. For example, the method for producing 5-difluorinated methyl 4-difluoride compound of item 1 in the scope of patent application, wherein in the general formula (2) is 〇3. As item 1 or 2 of the scope of patent application 5_ Method for producing difluoroprimary methyl gel compounds, which one. 4 · If the scope of patent application is 1 or 2 of 5 _ two gas production method of methylpyrazole compounds, where η is two. 5. The method for producing an oxy-4-thiomethylpyrazole compound according to any one of items 1 to 4 of the patent application, wherein the additive is carried out in the presence of β water trapping additives. 6. The method for producing 5-dimethoxypyridine difluoride compound according to item 5 of the scope of patent application, which has water trapping water as a group selected from the group consisting of anhydrous sodium sulfate, calcium chloride, and sodium carbonate. 0 I Where X of the methyl-4-thiomethyl group is chlorine, methoxy-4-thiomethoxy-4 -thio 5-difluoromethane [should be at least one of the additives for the 1 kind -29- 200540160 七、指定代表圖: (一) 、本案指定代表圖為:無 (二) 、本代表圖之元件代表符號簡單說明:無-29- 200540160 VII. Designated Representative Map: (1) The designated representative map in this case is: None (II) The component representative symbol of this representative map is simply explained: None 八、本案若有化學式時,請揭示最能顯示發明特徵的化學 式:8. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: r2、 N; -S(〇)n-R3 、OCHF2 Ri (3)r2, N; -S (〇) n-R3, OCHF2 Ri (3)
TW94113484A 2004-04-28 2005-04-27 Process for the production of 5-difluoromethoxy -4-thiomethylpyrazoles TW200540160A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004132764A JP2007246396A (en) 2004-04-28 2004-04-28 Manufacturing method of 5-difluoromethoxy-4-thiomethylpyrazole compound

Publications (1)

Publication Number Publication Date
TW200540160A true TW200540160A (en) 2005-12-16

Family

ID=35241607

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94113484A TW200540160A (en) 2004-04-28 2005-04-27 Process for the production of 5-difluoromethoxy -4-thiomethylpyrazoles

Country Status (3)

Country Link
JP (1) JP2007246396A (en)
TW (1) TW200540160A (en)
WO (1) WO2005105755A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114716428A (en) * 2022-05-06 2022-07-08 山东潍坊润丰化工股份有限公司 Method for preparing sulpyrazoxazole intermediate

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2333977T3 (en) 2004-10-05 2010-03-03 Syngenta Limited ISOXAZOLINE DERIVATIVES AND ITS USE AS HERBICIDES.
US7714142B2 (en) * 2004-12-20 2010-05-11 Ihara Chemical Industry Co., Ltd. Process for production of (4,5-dihydroisoxazol-3-Y) thio-carboxamidine salts
TWI443090B (en) 2007-05-25 2014-07-01 Abbvie Deutschland Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
EP2065373A1 (en) 2007-11-30 2009-06-03 Bayer CropScience AG Chiral 3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole and 5,5-dimethyl-3-[(1H-pyrazol-4-ylmethyl) sulfinyl]-4,5-dihydroisoxazole derivatives, methods for their preparation and their use as herbicides and plant growth regulators
JP5579866B2 (en) 2009-11-26 2014-08-27 ビーエーエスエフ ソシエタス・ヨーロピア Process for producing 5,5-disubstituted 2-isoxazoline
CN112969697A (en) 2019-10-31 2021-06-15 组合化学工业株式会社 Process for producing herbicide and intermediate thereof
WO2022137370A1 (en) * 2020-12-23 2022-06-30 クミアイ化学工業株式会社 Sulfone derivative production method
WO2023074828A1 (en) 2021-10-29 2023-05-04 クミアイ化学工業株式会社 Disulfide compound, polysulfide compound, and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4465133B2 (en) * 2001-02-08 2010-05-19 クミアイ化学工業株式会社 Isoxazoline derivatives and herbicides containing the same as active ingredients
JP4317445B2 (en) * 2001-06-21 2009-08-19 クミアイ化学工業株式会社 Isoxazoline derivatives and herbicides
TW200409758A (en) * 2002-08-01 2004-06-16 Ihara Chemical Ind Co Pyrazole derivatives and process for production thereof
UA78071C2 (en) * 2002-08-07 2007-02-15 Kumiai Chemical Industry Co Herbicidal composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114716428A (en) * 2022-05-06 2022-07-08 山东潍坊润丰化工股份有限公司 Method for preparing sulpyrazoxazole intermediate
CN114716428B (en) * 2022-05-06 2024-02-06 山东潍坊润丰化工股份有限公司 Method for preparing metazopyr intermediate

Also Published As

Publication number Publication date
WO2005105755A1 (en) 2005-11-10
JP2007246396A (en) 2007-09-27

Similar Documents

Publication Publication Date Title
TW200540160A (en) Process for the production of 5-difluoromethoxy -4-thiomethylpyrazoles
TW200536832A (en) Process for producing 5-hydroxy-4-thiomethylpyrazole compound
JPWO2010103783A1 (en) Method for producing 1-alkyl-5-benzoyl-1H-tetrazole derivative
US20190276430A1 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
WO1998003272A1 (en) Processes for the preparation of 4-amino-5-chloro-6-(1-fluoroethyl)pyrimidine compounds
EP2978750B1 (en) "synthesis of dabigatran"
JP6523334B2 (en) Method for the preparation of substituted cycloserines
JP2002542233A (en) Method for producing substituted pyrimidine
AU2006240772B2 (en) Method for producing nicotinic acid derivative or salt thereof
JP3720637B2 (en) New nitroisourea derivatives
JP6009851B2 (en) Method for producing 1H-tetrazole derivative
JPS63250385A (en) Production of halogenated heterocyclic compound
CN105008330A (en) Process for the preparation of bis-dihaloalkyl pyrazoles
US20200207725A1 (en) A process for the preparation of Deferasirox
TWI547489B (en) Process for the preparation of n-hydroxy-1-(1-alkyl-1h-tetrazol-5-yl)-1-phenylmethanimine derivatives
WO2002094798A1 (en) Process for preparation of thiazole compounds
WO2010116121A1 (en) Processes for making isoxazoline derivatives
JP4075357B2 (en) 4,5-disubstituted-1,2,3-triazole and process for producing the same
JP6305656B2 (en) Process for the preparation of certain 1,5-disubstituted tetrazoles
JP4706995B2 (en) Method for producing heterocyclic aromatic nitrile
EP1902023A2 (en) Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted heterocycles
JP2024503801A (en) Methods related to the formation of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-2-(methylsulfonyl)propanamide
WO2007005455A2 (en) Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted heterocycles
US20180201574A1 (en) Intermediate of preparing high-purity sulfonamide compound
JPH11140062A (en) Production of 2-substituted 5-formylthiazole